This content was funded by AstraZeneca, and is intended for US Healthcare Professionals.
How do urologists, oncologists, and advanced practice providers coordinate care in muscle-invasive bladder cancer (MIBC)?
This AMJ podcast brings together three leading experts in each speciality to explore best practices in MDT collaboration, patient transitions, and treatment strategy.
Listen now to strengthen your approach to MIBC care.
Chapters:
- 00:00 – 02:18 | Introductions
- 02:18 – 10:15 | MDT Collaboration & Best Practices
- 10:15 – 16:16 | Patient Pathway & Coordination
- 16:16 – 25:23 | Treatment Decisions & Strategy
- 25:23 – 33:38 | Immune-Mediated AR Management
- 33:38 – 38:52 | Key Takeaways
Speakers
Chandler Park, MD1
Gautam Jayram, MD2
Michael White, PA-C3
1. Medical Oncologist, Norton Cancer Institute; & Clinical Faculty, University of Louisville School of Medicine
2. Urologist, Urology Associates, Nashville, TN
3. Physician Assistant, Urology Partners of North Texas
